Conexeu Sciences (CNXU) vs Equillium (EQ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Conexeu Sciences is the larger company by market cap ($109.7 million vs $89.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNXU | EQ |
|---|---|---|
| Share price | $3.89 | $1.41 |
| Market cap | $109.72M | $89.41M |
| 1-day change | +12.75% | -2.08% |
| YTD return | — | -9.03% |
| 1-year return | — | -2.08% |
| 5-year return | — | -76.14% |
| EPS (TTM) | $-0.61 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.79 | $3.54 |
| 52-week low | $3.05 | $0.76 |
| Distance from 52-week high | -79.30% | -60.17% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +414.14% | +507.09% |
| Average volume | 205.86K | 583.72K |
| Shares outstanding | 28.21M | 63.41M |
| Employees | — | 14 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Conexeu Sciences
CNXU stock →Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
Health Care · Industrial Specialties
About Equillium
EQ stock →Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 14 employees
CNXU vs EQ FAQ
Which is bigger, Conexeu Sciences or Equillium?
Conexeu Sciences (CNXU) is larger, with a market capitalization of $109.72M compared with $89.41M for Equillium (EQ).
Are Conexeu Sciences and Equillium in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Conexeu Sciences and Biotechnology: Pharmaceutical Preparations for Equillium.